AKRO 241220 32.50C (AKRO241220C32500) Stock Options, News & Quotes - Moomoo

US OptionsDetailed Quotes

AKRO241220C32500

Watchlist

1.70
+0.65+61.90%

15min DelayTrading Nov 25 10:55 ET

1.80High1.45Low

Intraday

5D
Daily

News

Akero Therapeutics Receives Buy Rating for Promising Efruxifermin Developments in MASH Treatment
TipRanksNov 22 06:25 ET · Ratings
Akero a New Buy at Citi on Liver Disease Asset
Seeking AlphaNov 18 12:33 ET
Akero Therapeutics Price Target Announced at $65.00/Share by Citigroup
Dow JonesNov 18 07:51 ET · Ratings
Promising Potential of Akero Therapeutics' Efruxifermin Highlighted by Positive Phase 2b HARMONY Study Results
TipRanksNov 18 06:35 ET
Akero Therapeutics (AKRO) Receives a Buy From Phillip Securities
TipRanksNov 18 05:18 ET · Ratings
Promising Clinical Trial Results and Future Potential Justify Buy Rating for Akero Therapeutics
TipRanksNov 17 09:35 ET · Ratings

Comments

$Akero Therapeutics (AKRO.US)$ whats going on it started going up again?

$Akero Therapeutics (AKRO.US)$ Shitt stock

🔔 Baker Bros. Q1 ‘24* Holdings Released... 🐳

» Holdings: 87
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte (INCY.US)$
$BeiGene (BGNE.US)$
$ACADIA Pharmaceuticals (ACAD.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Revolution Medicines (RVMD.US)$
$Kymera Therapeutics (KYMR.US)$
$AbCellera Biologics (ABCL.US)$
$Bicycle Therapeutics (BCYC.US)$
$Edgewise Therapeutics (EWTX.US)$
$Immunocore (IMCR.US)$
$Kodiak Sciences (KOD.US)$
$Roivant Sciences (ROIV.US)$
...

🔔 Baker Bros. Q1 ‘24* Holdings Released... 🐳

10

$Akero Therapeutics (AKRO.US)$ has been sliding for month

$Akero Therapeutics (AKRO.US)$ Im done with medical stocks not a single one of these companies can make good decisions

Read more